Member Center       Download

Follow us

Free newsletter sign up

Sign up to our free newsletter and get the latest 

news sent direct to your inbox

Etta Biotech Co., Ltd.  Copyright © 2014-2018 All Rights Reserved.   苏ICP备13031692号-4

Subscribe

Products

产品名称

EBXP-F1

1) Super high cell solution treatment capacity, 3-250ml or 1.5e6-1.0e10 cells,expandable. 2) Flow HiDEN, Flow High Density Electrode Needle, is patented technology designed to create a highly ...
编号
Affiliate classification
重量
0.00
零售价
0.00
市场价
¥0.00
Quantity
-
+
库存
0
没有此类产品
Product Description
Product parameters
Technical Data
Application Field
Result Display
Customer Testimony
1. Product introduction
 
 
2. Product Features
1) Super high cell solution treatment capacity, 3-250ml or 1.5×107-1.0×1010 cells,expandable.
 
2) Flow HiDEN, Flow High Density Electrode Needle, is patented technology designed to create a highly even and stable electrical field under a lower valtage, which achieves high transfection efficiency and high viability.
 
3) In GMP workshop, production, sterilization and quality inspection of consumables are conducted according to GMP standards.
 
4) The special electroporation buffer (from Etta Biotech) can protect cells better and redcuce cell mortality, significantly enhancing the transfection efficiency.
 
5) Applied to R&D, testing and small amount preparation.
 
6) Reasonable and affordable equipment and consumable cost, obtaining an absolute dominance.
Corresponding parameter set not found, please add it in property template of background

Item

Parameter

Cell Type eukaryotic cell suspension
Optimal Cell Density 1×108 cells/ml 
Volume of single treatment 3-250 ml
Compatible Container Corning 15ml, 50ml, 250ml centrifugation tube
Velocity 1-50 ml/min
Electric Form Square Wave
Input Voltage 210-240 VAC
Output Voltage 30 - 600 VDC
Operation System Etta Biotech EBXP-F1 software
Operation System Platform Linux
Dimensions W623×D452×H325 mm
Weight Approx. 27 kg

 

1) R&D of new drugs: mainly used in small-batch preparation for protein/antibody, screening of antibody drug and screening of positive clone, etc. Providing a faster and more cost-effective solution for enterprises engaged in R&D of new drug and antibody production.
 
2) Cell immunotherapy research: applied to large-scale preparation for CAR-T, CAR-NK. Making the process more standardized in the R&D phase while making up for imperfection of the virus-vector scheme.
 

1. Some Demo Results

No content information display available

暂未实现,敬请期待
暂未实现,敬请期待
Key words :